AXIM · Axim Biotechnologies, Inc. · Financials
$0.00
+0.00 (+3.33%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 19, 2024
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments related to the recoverability of assets and classification of liabilities that might be necessary should the Company be unable to continue in operation.”View the 10-Q filed Aug 19, 2024
Market Cap
$905,876
Shares
301.96M
Volume · Oct 23
114K
Avg daily vol (3M)
387.06K
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$39.52K
+345.3%
FY2023
Net Income
-$8.06M
-29.1%
FY2023
Gross Margin
0%
-95.6pp
FY2019
Operating Margin
-6960.98%
+45464.6pp
FY2023
Diluted EPS
-$0.04
0%
FY2023
Operating Cash Flow
-$1.03M
+49.6%
FY2023
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $92.65K | $39.52K | $8875 | $60.46K | $0 | $799.48K | $195.61K | $47.57K | $47.06K | $49.14K | $0 | $21.67K | $43.33K | $10K | |
| — | — | — | — | $0 | $0 | $8511 | $42.86K | $154.13K | $50.39K | $0 | — | — | — | |
| — | — | — | — | $0 | $0 | $187.1K | $4716 | -$107.07K | -$1248 | $0 | — | — | — | |
| — | — | — | — | — | 0% | 95.65% | 9.91% | -227.53% | -2.54% | — | — | — | — | |
| $90.64K | $125.5K | $153.7K | $284.87K | $426.71K | $0 | $2.06M | $1.35M | $235.58K | $571.46K | $0 | — | — | — | |
| — | — | — | $5.67M | $4.51M | $3.11M | $3.16M | $1.8M | $3.41M | — | — | — | — | — | |
| $1.88M | $2.24M | $4.08M | $5.67M | — | — | — | — | $3.41M | $9.48M | $505.73K | — | — | — | |
| $394.45K | $394.45K | $394.45K | $2.09M | $0 | $3158 | $9475 | $0 | — | — | — | $10K | $5472 | $832 | |
| $429.65K | $427.02K | $426.13K | $2.12M | $16K | — | — | — | $3356 | $1119 | $0 | — | — | — | |
| $2.4M | $2.79M | $4.66M | $14.04M | $4.95M | $3.11M | $5.22M | $3.15M | $3.65M | $10.05M | $505.73K | $62.89K | $58.24K | $12.79K | |
| -$2.31M | -$2.75M | -$4.65M | -$13.97M | -$4.95M | -$3.11M | -$5.04M | -$3.15M | -$3.76M | -$10.05M | -$505.73K | — | — | — | |
| — | -6960.98% | -52425.6% | -23114.45% | — | -388.86% | -2574.53% | -6619.48% | -7988.83% | -20451.26% | — | — | — | — | |
| -$1.88M | -$2.32M | -$4.23M | -$11.86M | -$4.93M | — | — | — | -$3.76M | -$10.05M | -$505.73K | — | — | — | |
| — | — | — | $247.79K | $234.75K | $222.24K | $456.06K | $315.01K | $275.73K | $43.22K | $32.52K | — | — | — | |
| — | — | — | $1026 | $675 | — | $0 | $1597 | $0 | — | — | — | — | — | |
| $1.82M | $5.31M | $1.59M | $2.05M | $1.34M | $141.91K | -$1.72M | -$1.02M | -$2.05M | $43.22K | $32.52K | — | — | — | |
| -$4.14M | -$8.06M | -$6.24M | -$16.02M | -$6.29M | -$2.97M | -$6.75M | -$4.17M | -$5.81M | -$10.09M | -$538.25K | — | — | — | |
| $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | |
| -$4.14M | -$8.06M | -$6.24M | -$16.03M | -$6.41M | -$6.45M | -$6.75M | -$4.17M | -$5.81M | -$10.09M | -$582.95K | -$89.22K | -$14.9K | -$2794 | |
| — | -20394.96% | -70343.09% | -26517.21% | — | -806.47% | -3453.05% | -8761.7% | -12346% | -20539.22% | — | -411.77% | -34.39% | -27.94% | |
| — | — | -$6.24M | -$16.03M | -$6.41M | -$6.45M | -$6.75M | -$4.17M | -$7.28M | — | — | — | — | — | |
| — | — | — | — | $0 | $0 | — | — | — | — | — | — | — | — | |
| USD/shares | -$0.02 | -$0.04 | -$0.04 | $0.12 | -$0.06 | -$0.10 | — | — | — | — | — | — | — | — |
| USD/shares | -$0.02 | -$0.04 | -$0.04 | $0.12 | -$0.06 | -$0.10 | — | — | — | — | — | — | — | — |
| shares | — | — | — | — | 110.39M | 61.95M | 57.28M | 53.3M | 41.73M | 37.05M | 33M | 33M | 33M | 23.28M |
| shares | — | — | — | — | 110.39M | 61.95M | 57.28M | 53.3M | 41.73M | 37.05M | 33M | 33M | 33M | 23.28M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Capital lease obligations | 2024-06-30 | USD 186,492 | 10-Q filed 2024-08-19 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Current long-term debt and lease obligations | 2024-06-30 | USD 92,645 | 10-Q filed 2024-08-19 |
| Long-term debt, including current maturities | 2024-06-30 | USD 5,965,990 | 10-Q filed 2024-08-19 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Noncurrent long-term debt and lease obligations | 2024-06-30 | USD 93,847 | 10-Q filed 2024-08-19 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.